Skip to main content
. 2008 Sep 22;10(5):R79. doi: 10.1186/bcr2146

Table 1.

Correlation betweeen HMG-CoAR expression and clinicopathological parameters.

HMG-CoAR intensity 0 1 to 3
n (%) 111 (25.0) 333 (75.0) p value
Age (years)
Median 65 64
Range 27 to 89 34 to 96 0.84
≤50 23 (20.7) 51 (15.5)
>50 88 (79.3) 279 (84.5) 0.20
Tumour size (mm)
Median 20 15
Range 1 to 100 1 to 100 <0.001
≤20 mm 57 (51.4) 217 (65.8)
>20 mm 54 (48.6) 113 (34.2) 0.007
NHG
I 11 (9.9) 97 (29.5)
II 45 (40.5) 133 (40.4)
III 55 (49.5) 99 (30.1) <0.001
Node status
Negative 67 (65.7) 179 (61.3)
Positive 35 (34.3) 113 (38.7) 0.43
Unknown 9 41
ER status
Negative 22 (20.0) 36 (10.9)
Positive 88 (80.0) 294 (89.1) 0.01
Unknown 1 3
PR status
Negative 16 (14.8) 45 (13.8)
Positive 92 (85.2) 281 (86.2) 0.79
Unknown 3 7
n (%) 111 (25.0) 333 (75.0) p-value
Endocrine therapy (tamoxifen)
No 50 (55) 147 (59)
Yes 41 (45) 103 (41)
Unknown 20 83 0.53
Chemotherapy
No 81 (89) 240 (95)
Yes 10 (11) 12 (5)
Unknown 20 81 0.04
HER2 IHC
0 77 (73.3) 155 (48.9)
1 13 (12.4) 89 (28.1)
2 6 (5.7) 37 (11.7)
3 9 (8.6) 36 (11.4) <0.001
unknown 6 16
HER2 IHC
0 to 2 96 (91) 284 (89)
3 9 (9) 36 (11) 0.44
Unknown 6 16
Ki67
0 to 10% 29 (27.6) 122 (39.5)
11 to 25% 35 (33.3) 107 (34.6)
>25% 39 (41.0) 80 (25.9) 0.02
Unknown 8 24

ER = oestrogen receptor; HER2 = human epidermal growth factor receptor 2; IHC = immunohistochemistry; NHG = Nottingham histological grade; PR = progesterone receptor.

10% cut-off used for determination of hormone receptor status. Mann-Whitney test for comparison of medians and chi squared test for X × 2 tables. The categories marked as not done and unknown were not included in the analysis.